The Seminar Programme features presentations by leading exhibitors and organisations, highlighting the latest technologies, research, and industry developments in the pharmaceutical, biotechnology, and health functional food sectors.
Sessions open for walk-in attendance may be joined without prior registration. For sessions requiring advance registration, please register via the Conference/Seminar Registration page.

2026 Seminar Schedule - Hall C Seminar

K Korean   /   E English   /   ALL All Languages

2026 Hall C Seminar Schedule
Location Session Time Title Organization & Companies Speaker Language Attendance​​
08.25 (Tuesday)
Hall C Seminar Room C-0 10:20 - 10:50 Two Paths to Bioavailability: CurcuVail® and Liposomal Innovation (VesiMatrix™) K. PATEL PHYTO EXTRACTIONS PVT .LTD. Hana Oh, Assistant
Manager
K
 First Come, First Served
C-1 11:00 - 11:30 Unlocking the Future of Healthy Aging - Food Supplement Actives to Target the Hallmarks of Aging and Longevity. Mibelle Biochemistry Torsten Grothe, Head of Food Supplement
E
 First Come, First Served
C-2 11:40 - 12:10 Optimizing Human Health: Enhanced Bioavailability Through Liposome and DFS Technology Platforms ; Clinical Outcomes Botanic Healthcare Dr. H. N. Shivaprasad (Dr. Shiv)
E
 First Come, First Served
C-3 13:00 - 13:30 Beyond Skin Boosters: ECM-Driven Innovative Biomaterials for Aesthetic Injectables Bloomage Biotechnology Dion Kim, Sales Director
K
 First Come, First Served
C-4 13:40 - 14:50 When lipids go solid: process strategies to enhance bioavailability in oral dosage forms Gattefossé Hongyi Ouyang, Regional Technical Sales Manager
E
 First Come, First Served
C-5 15:00 - 15:30 From Oral Metabolic Peptides to Topical Drug Delivery: Caregen’s Next-Generation Peptide Platform Innovations Caregen Yongji Chung, CEO Ph.D CTO
K
 First Come, First Served
C-6 15:40 - 16:10 The New Age of Female Vitality: APAC Trends in Beauty-from-Within and overall women health SIRIO Even Zhang
Head of Product Solution, Sirio Pharma APAC
E
 First Come, First Served
C-7 16:20 - 16:50 Scientific Insights into Clostridium butyricum S-45-5 and Short-Chain Fatty Acids for Gut and Metabolic Health NPK Han Seong-jeong, Principal
Researcher/Ph.D
K
 First Come, First Served
08.26 (Wednesday)
Hall C Seminar Room C-20 10:20 - 10:50 Inner Nourishment & Outer Beauty: Integrating Cosmetic Ingredients with Functional Food Raw Materials – Bloomage Biotech’s Oral Nutritional Actives Empower a Holistic Health Ecosystem Bloomage Biotechnology Chelsea Zhang, Global Technical Solutions Director
K
 First Come, First Served
C-21 11:00 - 11:30 Beyond Bitterness: Innovative Taste Solutions for Pharmaceutical Products dsm-firmenich Shermaine Lee
Assoc Mktg Director, Pharma, APAC, HNC
KE
 First Come, First Served
C-22 11:40 - 12:10 Blocked Arteries, Calcified Arteries
Targeted Vascular and Bone Health Solutions with Nattokinase and Vitamin K2		 GF Fermentech Bokjun Park, Team Leader
K
 First Come, First Served
C-23 13:00 - 14:10 Clinical Trial Overview: Morinaga Milk Industry’s Human-Residential Bifidobacteria (HRB) and B. breve B-3 (Individually Approved Ingredient No. 2023-2) MORINAGA MILK INDUSTRY CO., LTD. Izen Ri, Assistant Manager
E
 First Come, First Served
C-24 14:20 - 14:50 The Future of Dietary Supplements: Consumer Insights Shaping Healthy Longevity dsm-firmenich Hock Yam Ng, Associate Mktg Director, DS, APAC, HNC
KE
 First Come, First Served
C-25 15:00 - 15:30 New Opportunities in Nutrition Science: GLP-1, Women’s Health, and Healthy Aging dsm-firmenich Kai Lin EK, Assoc Director HNC Regional Science APAC
KE
 First Come, First Served
C-26 15:40 - 15:55 Development of Novel Skin-Improving Materials Using Bioconversion Products as Active Ingredients National Institute of Biological Resources (NIBR) Wonjae Chi,
Researcher
K
 First Come, First Served
15:55 - 16:10 Development of Microbe-Derived Peptides as Anticancer Candidates Nakdonggang National Institute of Biological Resources Jayoung Cho,
Associate Researcher
K
16:20 - 16:35 Island and Coastal Biological Resources:
Their Application for Enhancing Health Function and Environmental Improvement		 Honam National Institute of Biological Resources Jaehyoung Joo,
General Manager
K
16:35 - 16:50 From Mycelium to Fabric: An Ecomimetic Approach to Fungal-Based Textiles National Institute of Ecology Jukyeong Eo,
Senior researcher
K
08.27 (Thursday)
Hall C Seminar Room C-30 10:20 - 10:50 Long Pepper Extract: A Natural Solution for Cold Sensitivity & Leg Swelling MARUZEN PHARMACEUTICALS Momoka Kajita
K
 First Come, First Served
C-31 11:00 - 11:30 Bioequivalence Studies: Practical Insights from a Leading Contract Research Organization in Indonesia PT BIOMETRIK RISET INDONESIA Andi Darmawan, Head of Technical Operation
E
 First Come, First Served
C-32 11:40 - 12:10 New Individually Recognized 'Fermented Rice Germ Powder': A Dual-Care Solution for Sleep and Skin Health NEWTREE Taejong Kim, Director
K
 First Come, First Served
C-33 13:00 - 13:30 Sucrosomial® Technology: Breakthrough SynergyBio (Pharmanutra) Lorenzo Ligabue, Senior Operations Officer
E
 First Come, First Served
C-34 13:40 - 14:10 A national treasure 'Antrodia cinnamomea' in Taiwan, Revolutionary technology to cultivate its mycelium & R&D for Hepatoprotection and Immunomodulation SynergyBio (Greenyn) Leon Hsu, CEO
E
 First Come, First Served

* The above schedule is subject to change without prior notice.

2026 Seminar Schedule - Hall E1 Seminar

K Korean   /   E English   /   ALL All Languages

2026 Hall E1 Seminar Schedule
Location Session Time Title Organization & Companies Speaker Language Attendance​​
08.25 (Tuesday)
E1 Seminar Room (Hall E) E-1 11:30 - 12:20 Malaysia's Regulatory Requirements for Pharmaceutical Product Registration NPRA Zarina Rosli, Senior Principal Assistant Director
KE
 Register
E-3 14:00 - 17:00 [Paid] Global Business Expansion Buildup ① - Japan Market Trend Analysis and Global BD Success Cases Korea Institute of Toxicology (KIT), HekaBio K.K. Robert E. Claar, CEO
KE
 Register
08.26 (Wednesday)
E1 Seminar Room (Hall E) E-20 10:20 - 11:40 Recent Trends in Japanese Pharmaceutical Regulations Japan Pharmaceutical Traders' Association (JPTA) Ichiro Fujikawa, Chair person
KJ
 Register
E-21 13:00 - 14:50 Technical Briefing on Outstanding Functional Material Patents National Institute of Agricultural Sciences Register
13:05 - 13:25 Black Ginseng Prebiotics & Turmeric for Body Fat Reduction National Institute of Horticultural and Herbal Science Youngseob Lee,
Research Scientist
K
13:25 - 13:45 Processing Technologies for Astragalus membranaceus (Cognitive Function) and Gastrodia elata (Deodorization) National Institute of Horticultural and Herbal Science Jang Gwi Yeong,
Researcher
K
13:45 - 14:05 Patents of Materials from Horticultural and Herbal Crops National Institute of Hurticultural and Herbal Science Sangsuk Kim,
Senior Researcher
K
14:05 - 14:25 Introduction of Functional Food Crop Materials: Soybean Seedlings for Periodontal Disease Management and Adzuki Bean Seedlings for Glycemic Control National Institute of Crop and Food Science Jieun Ra,
Senior Researcher
K
14:25 - 14:45 Composition for improving cognitive function comprising Amaranthus mangostanus L. extract as an active ingredient National Institute of Crop and Food Sciencee Inguk Hwang,
Researcher
K
08.27 (Thursday)
E1 Seminar Room (Hall E) E-30 10:20 - 10:50 The impact of the Functional Food with Claims Japan Alliance of Health Food Associations (JAOHFA)​ Hidekazu Kawakubo,
Chairman
KE
 Register
E-31 11:00 - 11:30 The AI Compass: Navigating the Next Frontier of Functional Foods INSIGHTFI Co., Ltd. Bokkyung Han, CEO
K
 First Come, First Served​
E-33 13:00 - 16:00 [Paid] Global Business Expansion Buildup ② - China Market Trend Analysis and Global BD Success Cases Korea Institute of Toxicology (KIT), Yafo Capital Fan Zheng, Managing Partner, Execution
KE
 Register

* The above schedule is subject to change without prior notice.

2026 Seminar Schedule - E2 Seminar

K Korean   /   E English   /   ALL All Languages

2026 E2 Seminar Schedule
Location Session Time Title Organization & Companies Speaker Language Attendance​​
08.26 (Wed)
E2 Seminar Room (Hall E) E2-0 14:00 - 17:00 Briefing on Promising Technologies for Commercialization of Korean Medicine Materials National Institute for Korean Medicine Development (NIKOM) First Come, First Served​
14:15 - 16:15 Osteoporosis prevention subject matter Kyung Hee University Hyuksang Jeong, Professor
K
Relief of benign prostatic hyperplasia subject matter Kyung Hee University Jeongbin Song, Professor
K
Improvement of cognitive impairment subject matter Konkuk University Dongguk Choi, Professor
K
Strengthening muscles subject matter Korea Institute of Oriental Medicine Gwanghoon Song, Doctor
K
Prevention of muscle loss subject matter Korea Institute of Oriental Medicine Youngsook Kim, Doctor
K
Method for Manufacturing a Foaming Agent Containing Naphthenic Acid National Institute for Korean Medicine Development (NICOM) Jungok Kim, Doctor
K
Technology for Preventing Inflammatory Bowel Disease Using Self-Extraction Extract Gyeongsang National University Kwangil Park, Professor
K
Natural blend extract-based antioxidant and hair health composition Daegu Haany University Jinhan Park, Professor
K
14:00 - 17:00 1:1 Consultations on Outstanding Research Achievements National Institute for Korean Medicine Development (NICOM)
14:00 - 17:00 Banner Exhibition of Presented and Featured Technologies National Institute for Korean Medicine Development (NICOM)

* The above schedule is subject to change without prior notice.

2026 Seminar Schedule - The Platz Seminar

K Korean   /   E English   /   ALL All Languages

2026 The Platz Seminar Schedule
Location Session Time Title Organization & Companies Speaker Language Attendance​​
08.25 (Tuesday)
The Platz Seminar Room P-0 10:00 - 12:00 K-Bio Innovation Modality & Tech Commercialization Korea Institute of Toxicology (KIT) Register
10:00 - 10:20 K-Bio Modality & Tech Commercialization 1004 VenturePartners Soyoung Park,
CEO
KE
10:25 - 10:40 Innovative ADC Technology Cyron Therapeutics Sangsoon Yoon,
CEO
K
10:40 - 10:55 Innovative TPD Technology UPPthera Siwoo Choi,
CEO
K
10:55 - 11:10 Innovative Radiopharmaceuticals VS PharmTech Hoyun Nam,
Director
K
11:10 - 11:25 Next-Generation Quantum Drug Discovery Technologies Quantum Intelligence Keunsu Choi,
Principal Researcher
K
11:25 - 11:55 Global Commercialization of K-Bio
P-1 12:50 - 14:20 2026 Regenerative Medicine Investment Strategy & IR Partnering Day Korean Fund for Regenerative Medicine (KFRM) Register
13:00 - 13:15 Introduction about TIPS Program Korea Business Angels Association (KBAA) Ingyu Yoon,
Team Manager
K
13:15 - 13:30 SCALEUP TIPS: Program and Key Cases Korea Venture Capital Association (KVCA) Changyeon Lee,
Team Manager
K
13:30 - 13:37 EGC Therapeutics IR EGC Therapeutics
K
13:37 - 13:44 DentXbiomed IR DentXbiomed
K
13:44 - 13:51 KAIMEDIX IR KAIMEDIX
K
13:51 - 13:58 AVANTRIX IR AVANTRIX
K
13:58 - 14:05 KW-BIO IR KW-BIO
K
14:05 - 14:12 PLABiologics IR PLABiologics
K
14:12 - 14:19 epibiotech IR epibiotech
K
P-3 15:10 - 16:00 PSCI – Driving Responsible Pharmaceutical Supply Chains: Best Practices and Insights Boehringer-Ingelheim Korea Hyungseok Kim, GFE Manager
ALL
 Register
Samsung Biologics James Choi, Executive Vice President
ALL
08.26 (Wednesday)
The Platz Seminar Room P-20 10:00 - 12:00 Seminar on AI-based Drug Development Trends and Future Activation Strategy Korea Biomedicine Industry Association (KoBIA) Register
10:00 - 10:30 Global AI-Driven New Drug Development Market Trends Kyung Hee University Hwajin Lee, Assistant Professor
K
10:30 - 11:00 New Era: Way to Autonomous Scientific Discovery — Empowered by AI & Robotics Infrastructure XtalPi Jaesung Hwang, Director of Business Development
K
11:00 - 11:30 Practical Strategy for AI Drug Development Designed with LLM Multi-Agent AICADD Younghoon Kim, Founder
K
11:30 - 12:00 AI doesn't Create Drug! Korea Health Industry Development Institute Minseok Kim, PhD, MBA, Principal Researcher
K
P-21 13:30 - 14:00 Revolutionizing RNAi with SAMiRNA® siRNAgen Therapeutics Chungeun Lee, Chief Scientific Officer
K
 First Come, First Served​
P-23 15:00 - 17:00 Integrated Strategies for Biopharmaceutical Development: Raw Materials, Quality Innovation, and Commercialization Success Vaccine Center for Assisting Safety & Technology (K-VCAST) Register
15:00 - 15:20 Introduction of regulatory trends and test method development for Extractables and Leachables in disposable containers KMEDIhub Sujin Lee, Lead Researcher
K
15:20 - 15:40 National Cell Bank & Cell Line Characterization, Q-Safety Technical Support System K-VCAST Joonho Hong, Team Manager
K
15:40 - 16:00 Building Infrastructure for the Localization of Biopharmaceutical Materials and Parts CBTP Hyeongmin Jeong,
Senior Researcher
K
16:00 - 16:20 Success Stories of Cell Culture Media and Future Directions for Korea's Bioprocess Raw Materials Industry XCELL Sean Lee, Director
K
16:20 - 16:40 Status of Domestic Localization of Raw Material Resins and Government Support Directions Puriogen Ilgwon Kim, Team Manager
K
08.27 (Thursday)
The Platz Seminar Room P-30 10:00 - 12:20 DIPS Global Clinical Study Korea Institute of Toxicology (KIT) Register
10:00 - 10:40 Changes in the Global Clinical Trial Market (Technology, Capital, Regulation) TRIALIGN Consulting Sally Bang,
CEO
K
10:40 - 11:20 Understanding and Utilizing Human POC Polara Research Daniel Zang, PhD, JD
President/Founder
K
11:30 - 12:10 Leveraging RWD for Full Lifecycle Drug Development SELTA SQUARE INC. Hyejung Lee,
Director
K

* The above schedule is subject to change without prior notice.

2026 Seminar Schedule - IR Pitching (The Platz Hall)

K Korean   /   E English   /   ALL All Languages

2026 IR Pitching Schedule
Location Session Time Title Organization & Companies Speaker Language Attendance​​
08.25 (Tuesday)
IR Pitching
(The Platz Hall)		 IR-0 13:00 - 13:20 Adapting to the growing trends in the LNP industry – Bioconjugation and Lyophilization CordenPharma Dr. Matthieu Giraud, Senior Director, Global Platform Head Lipids & Nanomedicines Services
E
 First Come, First Served​
IR-1 13:50 - 16:10 KHU·CUK·CNU Tech-Transfer Forum KHU·CUK·CNU First Come, First Served​
14:00 - 14:20 Immune biomarker set for predicting lymph node metastasis in cancer College of Medicine, Catholic University of Korea Jooyeon Jhun,
Ph.D. Research Professor
K
14:20 - 14:40 Mitochondria-targeting compounds for the treatment of transplant-related diseases College of Medicine, Catholic University of Korea Jooyeon Jhun,
Ph.D. Research Professor
K
14:40 - 15:00 Auraptene–tanshinone formulation for cognitive function and memory enhancement College of Medicine, Chungnam National University Junyoung Heo,
Professor
K
15:00 - 15:20 A method for evaluating alternative splicing efficiency using multiplex Real-Time PCR Department of Biochemistry, College of Natural Sciences, Chungnam National University Namjoon Cho,
Professor
K
15:30 - 15:50 Marine-derived extracts with anticancer activity against oral cancer College of Medicine, Kyung Hee University Minjung Kim,
Ph.D.
K
15:50 - 16:10 A natural product, 6-shogaol, based solutions for age-related disorders: Advancing immune, brain, and ocular health College of Pharmacy, Kyung Hee University Myungsook Oh,
Professor
K
08.26 (Wednesday)
IR Pitching
(The Platz Hall)		 IR-20 10:20 - 12:00 KIT-KIBO Startup Growth Support Program KIBO, Korea Institute of Toxicology (KIT)
K
 Register
10:30 - 10:40 Program Process & Results KIBO Heonseok Bae, Team Leader
K
10:40 - 11:40 Investment-linked IR pitching of 7 DIPS companies
K
11:40 - 11:55 Outstanding Company Certification (1 Company)
K
Outstanding IR Pitching Company Award (3 Companies)
K
IR-21 13:30 - 17:00 DIPS Global Open Innovation Day Korea Institute of Toxicology(KIT)
KE
 Register
13:30 - 13:50 Trends & Case Studies in Global Bio Open Innovation Curi Bio NickGeisse, CEO
E
13:50 - 14:05 Needs Presentation & Collaboration Plans Daewoong Pharmaceutical
K
14:05 - 14:20 Tech IR of 2 DIPS Companies
K
14:20 - 14:35 Needs Presentation & Collaboration Plans GC Biopharma
K
14:35 - 14:50 Tech IR of 2 DIPS Companies
K
15:00 - 15:15 Needs Presentation & Collaboration Plans Ildong Pharmaceutical
K
15:15 - 15:30 Tech IR of 2 DIPS Companies
K
15:30 - 15:45 Needs Presentation & Collaboration Plans Boehringer Ingelheim Korea
K
15:45 - 16:00 Tech IR of 2 DIPS Companies
K
16:00 - 16:15 The Investment Delivery System for GCC Countries Korea DevelopmentBank(KDB)
K
16:15 - 16:30 Tech IR of 2 DIPS Companies
K

* The above schedule is subject to change without prior notice.